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http://dx.doi.org/10.1016/j.ajic.2015.07.004Objective: To measure the impact of an antimicrobial stewardship (AMS) program on the use of anti-
biotics for surgical prophylaxis at acute care hospitals in Egypt.
Methods: This was a before-and-after intervention study conducted in 5 tertiary, acute-care surgical
hospitals. The baseline, intervention, and follow-up periods were 3, 6, and 3 months, respectively. The
impact of the intervention was measured by preintervention and postintervention surveys for surgical
patients with clean and clean-contaminated wounds. Information was collected on demographic char-
acteristics and antibiotic use. The intervention focused mainly on educating surgical staff on the optimal
timing and duration of antibiotics used for surgical prophylaxis. Only 3 hospitals identiﬁed a surgeon to
audit antibiotic surgical prescriptions. The primary outcome measures were the percentages of surgical
patients receiving optimal timing and duration of surgical prophylaxis.
Results: Data were collected for 745 patients before the intervention and for 558 patients after the inter-
vention. The optimal timing of the ﬁrst dose improved signiﬁcantly in 3 hospitals, increasing from 6.7% to
38.7% (P < .01), from 2.6% to 15.2% (P< .01), and from 0% to 11% (P< .01). All hospitals showed a signiﬁcant
rise in the optimal duration of surgical prophylaxis, with an overall increase of 3%-28% (P < .01). Days of
therapy per 1000 patient-days were decreased signiﬁcantly in hospitals A, B, C, and D, with no change in
hospital E.
Conclusions: An AMS program focusing on education supported by auditing and feedback can have a
signiﬁcant impact on optimizing antibiotic use in surgical prophylaxis practices.
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T. Saied et al. / American Journal of Infection Control 43 (2015) e67-e71e68The excessive and inappropriate use of antibiotics in acute care
hospitals is common in developing and developed countries,1,2 and
is associated with emergence of antimicrobial resistance, prolonged
hospital stays, and high costs of health care.3 Several studies
have shown that approximately 30% of antimicrobial use is
inappropriate or suboptimal.4,5 In the developing countries of the
eastern Mediterranean region, limited studies have documented the
inappropriate use of antibiotics in hospitals.6,7 In Egypt, a point
prevalence survey of antibiotic use was conducted in 18 Egyptian
hospitals in March 2011 using the European Surveillance of Antimi-
crobial ConsumptionNetworkmethodology.8 Among 3194 antibiotic
prescriptions, surgical prophylaxis accounted for 38.4% of overall
antibiotics prescribed in the hospitals, and 66.5% of the antibiotics
prescribed in the surgical departments. Two percent of the antibi-
otics prescribed for surgical prophylaxis were given within 1 hour
before incision and discontinued within 24 hours after the surgery.9
Consequently, we aimed to pilot an antimicrobial stewardship
(AMS)programtooptimizeantimicrobial use for surgical prophylaxis,
focusing on the education of surgeons to promote optimal timing and
duration of surgical prophylaxis. The impact of the intervention was
measured through repeated surveys measuring antibiotic
prescribing practices related to surgical prophylaxis.
METHODS
Setting
This intervention study was performed at 5 tertiary acute care
surgical hospitals performing a variety of surgical procedures,
including general surgeries (eg, herniorrhaphy, colectomy), ortho-
pedic surgeries (eg, joint replacements, spinal fusion), and obstetric
and gynecologic surgeries. All 5 hospitals have functioning infection
control programs with full time infection control teams (Table 1).
None of the hospitals had any previous activity related to AMS.
Study design
Preintervention and postintervention surveys were conducted
to measure the antibiotic prescribing practices of surgical prophy-
laxis for clean and clean-contaminated elective surgeries before
and after implementation of the AMS program. The preintervention
surveys were conducted between January and March 2013, the
interventions were performed between April and September 2013,
and the postintervention surveys were done between October and
December 2013.
Study patients
All surgical patients undergoing clean or clean-contaminated
operations at select surgical wards were enrolled in the surveys.
Patients of all ages were eligible to participate. A standardized data
collection form was completed for each enrolled patient, on which
information was collected on patient demographics, surgery type
and date, indication for antibiotic use, and dose and duration of
antimicrobial therapy. Hospital infection control teams extracted
the data from the patient ﬁles and drug prescription sheets. A
sample size of 473 surgeries was required for both the pre-
intervention and postintervention surveys to detect an improve-
ment in the timing and duration of surgical prophylaxis ranging
from 24% to 48% (a ¼ 0.05 and 80% power).
Intervention
The 6-month AMS intervention aimed to launch appropriate
strategies for improving the timing of the ﬁrst dose before surgeryand the duration of antimicrobial therapy for clean and clean-
contaminated surgeries. The intervention targeted hospital staff
responsible for surgical prophylaxis, who were either surgeons or
anesthesiologists.
Leadership
Leadership of the AMS program was established within the
scope of the hospital’s infection control team. The elements of the
AMS were developed by the hospital infection control teams
through advocacy workshops with senior surgeons and pharma-
cists, and hospital administration approved the plan. They all
agreed that education of surgeons on the international guidelines
for surgical prophylaxis would form the basis of the AMS activities.
Education
Education targeted personnel responsible for surgical prophy-
laxis procedures, who were either surgeons or anesthesiologists. A
2-day training curriculumwas developed focusing on the principles
of antibiotic use for surgical prophylaxis, such as the type of op-
erations eligible for surgical prophylaxis, optimal timing of the ﬁrst
dose, and duration of postoperative antibiotic use.10 In addition, on-
the-job training on the optimal use of antibiotics was provided to
junior surgeons and residents during morning rounds. A
wall-mounted poster was developed to remind prescribers of the
optimal timing and duration of antibiotic administration for sur-
gical prophylaxis.
Auditing and feedback
Three of the 5 participating hospitals (hospitals B, D, and E)
nominated a senior surgeon as a champion to audit antibiotic
prescriptions for surgical prophylaxis and provide feedback to the
prescribers. The senior surgeon visited the surgical departments at
least twice weekly and reviewed the documented prescribed an-
tibiotics in the patient records. In the event that the patient ﬁle
speciﬁed suboptimal timing of the ﬁrst dose, noted suboptimal
duration of surgical prophylaxis, or lacked sufﬁcient information on
the antibiotics prescribed, the senior surgeon discussed the anti-
biotic prescription plan with the prescriber and provide feedback.
Outcome measures
The outcome measure was the change in the proportion of sur-
gical patients who received optimally timed prophylaxis, deﬁned as
the proportion of patients who received at least one prophylactic
dose administered within 60 minutes before the incision (120 mi-
nutes for the administration of ﬂuoroquinolones or vancomycin).
Whenmore than 1 antibioticwas administered, timingwas based on
the antibiotic given closest to the time of the incision. The second
primary outcome was the change in the proportion of surgical pa-
tients inwhom duration of the antibiotic prophylaxis was no longer
than 24 hours after the completion of surgery.
Secondary outcomemeasure was the changes in days of therapy
(DOT; the number of days on which a patient receives at least 1
dose of an antibiotic for surgical prophylaxis, summed for each
antibiotic/1000 patient-days). Patient-days were calculated as the
sum of lengths of hospital stay for each individual patient.
Statistical analysis
Statistical analyses were performed using Stata version 12 (Sta-
taCorp, College Station, TX). Proportions were compared using the
Z-test, andratesof antimicrobial use (measuredbyDOT/1000patient-
days) were compared using incidence rate ratios (IRRs). All statistical
tests were 2-tailed; a P value .05 was considered signiﬁcant.
Table 2
Characteristics of surgical patients and procedures in the pre and post intervention
periods
Characteristic
Preintervention
(n ¼ 745)
Postintervention
(n ¼ 558)
Age, y, mean  SD (range) 29.9. 14.1 (1-80) 31.5  12.6 (1-80)
Length of hospital stay, d,
mean  SD (range)
4.3  5.0 (1-38) 5.1  5.6 (1-31)
Sex, n (%)
Male 215 (28.9) 83 (14.9)
Female 530 (71.1) 475 (85.1)
Hospital, n (%)
Hospital A 139 (18.7) 95 (17.0)
Hospital B 150 (20.1) 150 (26.9)
Hospital C 198 (26.6) 105 (18.8)
Hospital D 154 (20.7) 99 (17.7)
Hospital E 104 (14.0) 109 (19.5)
Surgeries done, n (%)
Obstetrics and gynecology 343 (46.0) 341 (61.1)
General surgery 204 (27.4) 112 (20.1)
Orthopedics 198 (26.6) 105 (19.9)
Wound type*
Clean 417 (56.0) 301 (53.9)
Clean-contaminated 319 (44.0) 256 (45.9)
*Data on wound type are unavailable for 9 surgical patients in the preintervention
period and 1 surgical patient in the postintervention period.
Table 1
Characteristics of the 5 acute care tertiary hospitals in this study
Characteristic Hospital A Hospital B Hospital C Hospital D Hospital E
Number of beds 300 180 280 320 180
Type of surgery assessed General surgery General surgery, ob/gyn Orthopedics Ob/gyn Ob/gyn
Full-time IC team Yes Yes Yes Yes Yes
No. of IC team members 3 3 2 3 2
Ratio of IC personnel to hospital beds 1:100 1:60 1:160 1:100 1:90
Intervention activities
Education Yes Yes Yes Yes Yes
Audit and feedback No Yes No Yes Yes
IC, infection control; ob/gyn, obstetrics and gynecology.
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Among the 5 participating hospitals, the number of beds varied
from 180 to 320. All of the hospitals had a functioning infection
control program with a full-time hospital infection control teams.
None of the hospitals had previous experience in promoting anti-
biotic use or consumption (Table 1).
Data were collected for 745 surgical patients before the inter-
vention and for 558 surgical patients after the intervention. The
characteristics of the patient population, including age, sex, length
of hospital stay, and type of surgery, were recorded. The 1303
patients included 1005 females (77.1%), and the mean patient age
was 30.1 years. Descriptive data for patients in the preintervention
and postintervention surveys are compared in Table 2.
The overall proportion of patients who received optimal anti-
microbial prophylaxis initiated within 1 hour before the surgical
incision was 37.6% in the preintervention period and 41.6% in the
postintervention period, a statistically nonsigniﬁcant change
(Table 3). The impact of surgical AMS varied across the 5 hospitals,
however. There was a signiﬁcant rise in the proportion of optimal
timing of the ﬁrst dose in hospitals B, D, and E. In hospital B, the
proportion of patients receiving a prophylactic dose of antibiotics
within 60 minutes of the incision increased from 6.7% to 38.7%
(P < .0001). In hospitals D and E, where the baseline rate of optimal
timing of the ﬁrst dose was generally low (2.6% in hospital D and 0%
in hospital E), there was a signiﬁcant increase in optimal timing,
from 2.6% to 15.2% in hospital D and from 0% to 11% in hospital E.
Hospital C had a high baseline rate of 88.4% for optimal timing ofthe ﬁrst dose of surgical prophylaxis, but showed no signiﬁcant
change after the intervention. Hospital A was the only hospital
exhibiting a signiﬁcant reduction in the rate of optimal timing of
surgical prophylaxis, from 67.6% to 52.6% (P ¼ .021).
Regarding the optimal duration of surgical prophylaxis, the
overall preintervention proportionwas very low (3%), ranging from
0% in hospital A to 7.6% in hospital C. A signiﬁcant rise was observed
after the intervention, from 3% to 28.7% (P <.01). Hospitals B, C, D,
and E demonstrated signiﬁcant increases in the proportion of
optimal duration of surgical prophylaxis.
A signiﬁcant reduction in the amount of antimicrobials used for
surgical prophylaxis was observed in 4 hospitals (Table 4). The use
of drugs for surgical prophylaxis decreased from 843 DOT/1000
patient-days in the preintervention period to 335 DOT/1000
patient-days in the postintervention period (IRR, 0.40; 95% conﬁ-
dence interval [CI], 0.34-0.47; P < .001) in hospital A, from 1321
DOT/1000 patient-days in the preintervention period to 1090 DOT/
1000 patient-days in the postintervention period (IRR, 0.82; 95% CI,
0.71-0.95; P ¼ .011) in hospital B, from 465 DOT/1000 patient-days
in the preintervention period to 264 DOT/1000 patient-days in the
postintervention period (IRR, 0.57; 95% CI, 0.5-0.65; P <.001) in
hospital C, and from 669 DOT/1000 patient-days in the pre-
intervention period to 336 DOT/1000 patient-days in the post-
intervention period in hospital D (IRR, 0.50; 95% CI, 0.41-0.60; P <
.001). Hospital E showed no signiﬁcant change in the amount of
antimicrobial use from the preintervention period to the post-
intervention period (IRR, 0.89; 95% CI, 0.89-1.09; P ¼ .296).
DISCUSSION
This AMS pilot study found that inappropriate surgical pro-
phylaxis, including suboptimal timing of the ﬁrst dose and duration
of antibiotic use, was common in the 5 participating hospitals. It
also demonstrated that an AMS with focused intervention by
educating surgeons can have an impact on optimizing antimicro-
bial use for surgical prophylaxis of varying degrees for different
hospitals.
To the best of our knowledge, this study piloting AMS for anti-
microbial use in surgical prophylaxis is the ﬁrst in Egypt. None of
the 5 participating hospitals, even with a full-time hospital infec-
tion control team, has ever promoted general antibiotic use or
antibiotic use for surgical prophylaxis. The extremely high baseline
rates of suboptimal timing (62%; range, 11.6 - 100%) and duration of
surgical prophylaxis (97%; range, 92.4%-100%) were expected
despite the available evidence from several studies that the optimal
timing and duration of surgical prophylaxis reduce the resistance of
microorganisms and increase the efﬁcacy of antibiotics in reducing
bacterial counts at surgical sites.10-13
Several interacting factors account for the inappropriate surgical
prophylaxis in Egyptian hospitals; for example, only a limited
number of hospitals have policies, regulations, or guidelines on
general antimicrobial use, and speciﬁcally for surgical prophylaxis,
Table 3
Surgical antimicrobial prophylaxis before and after the intervention (timing and duration of surgical prophylaxis)
No. of surgeries Optimal timing of the ﬁrst dose* Optimal postoperative durationy
Baseline Intervention Baseline, n (%) Intervention, n (%) P value Baseline, n (%) Intervention, n (%) P value
Hospital
A 139 95 94 (67.6) 50 (52.6) <.05 0 0 d
B 150 150 10 (6.7) 58 (38.7) <.001 2 (1.3) 43 (28.7) <.001
C 198 105 175 (88.4) 97 (92.4) .28 15 (7.6) 32 (30.5) <.001
D 154 99 4 (2.6) 15 (15.2) <.001 1 (0.7) 40 (40.4) <.001
E 104 109 0 12 (11) <.001 4 (3.9) 45 (41.3) <.001
Total 745 558 283 (37.6) 232 (41.6) .49 22 (3) 160 (28.7) <.001
Operation type
Ob/gyn 343 341 17 (5.0) 90 (26.4) <.001 5 (1.5) 128 (37.5) <.001
General surgery 204 112 91 (44.6) 45 (40.2) .45 2 (1.0) 0 .38
Orthopedic 198 105 175 (88.4) 97 (92.4) .28 15 (7.6) 32 (30.5) <.001
Wound type
Clean 417 301 251 (60.2) 164 (54.5) .127 21 (5.0) 103 (34.2) <.001
Clean-contaminated 319 256 26 (8.2) 68 (26.6) <.001 1 (0.3) 56 (21.9) <.001
Surgery type
Open 664 508 221 (33.3) 201 (39.6) <.05 19 (2.9) 134 (26.4) <.001
Scopes 56 40 46 (82.1) 29 (72.5) .26 3 (5.4) 17 (42.5) <.001
*Optimal timing of the ﬁrst dose: At least one prophylactic dose administered within 60 minutes before incision (120 minutes for the administration of ﬂuoroquinolones or
vancomycin).
yOptimal postoperative duration: Duration of the antibiotic prophylaxis no longer than 24 hours after completion of surgery.
Table 4
Rates of antimicrobial use, based on DOT per 1000 patient-days
DOT/1000
patient-days Hospital A Hospital B Hospital C Hospital D Hospital E
Baseline 843 1321 465 669 606
Postintervention 335 1090 264 336 541
IRR 0.40 0.82 0.57 0.50 0.89
95% CI 0.34-0.47 0.71-0.95 0.5-0.65 0.41-0.60 0.89-1.09
P value <.001 <.05 <.001 <.001 .29
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mandates available in Egypt to optimize the use of antimicrobial
therapy through AMS. The lack of national guidelines on surgical
prophylaxis, the general perception of clinicians and surgeons
regarding the protective role of antibiotics in preventing infections,
the belief that longer duration of surgical prophylaxis will reduce
surgical site infections, and the perception of an extremely unclean
environment and its association with acquiring surgical site in-
fections are all factors contributing to the inappropriate use of
antibiotics.
The AMS resulted in signiﬁcant improvements in the timing of
the ﬁrst dose of surgical prophylaxis in hospitals in which the
baseline rates of optimal timing of the ﬁrst dose were extremely
low (hospitals B, D, and E), ranging from 0 to 6.7%. Even though the
change in rates was statistically signiﬁcant, the rates of optimal
timing in the postintervention period ranged from only 11% to
38.7%. The low rates of compliance after the intervention may be
explained by logistical issues regarding the provision of antibiotics
to surgical patients. In the majority of hospitals, patients received
surgical prophylaxis in the surgical ward before being transferred
to the operating theater (OT), and the time interval before the
incision usually exceeded 1 hour, owing to either delays in the
transportation of the patient to the OT or prolonged preoperative
preparation. Despite recommendations by the hospital infection
control teams to administer the surgical prophylaxis in the OT,
many hospitals failed to change their practices. In hospital A, the
rate of optimal timing of surgical prophylaxis decreased signiﬁ-
cantly after the intervention (from 67.6% to 52.6%). This could be
attributed to the high turnover rate of surgeons in the wards, many
of whom missed the education sessions. Hospital C did not show
any signiﬁcant change in the proportion of surgical patients pro-
vided with optimal timing of the ﬁrst dose, but its preintervention
rate was high (88.4%) compared with that of the other hospitals.The results of this study show signiﬁcant improvements in all 5
hospitals in terms of the duration of surgical prophylaxis. However,
the rate of optimal duration in the postintervention period ranged
from 28.7% to 41.3%. This change is considered favorable, because
the baseline rates of optimal duration of surgical prophylaxis were
extremely low (ranging from 0 to 7.6%). Lower compliance was
noted from surgeons regarding the duration of surgical prophylaxis
compared with the start time. Restricting the duration to only
24 hours after the completion of surgery was not acceptable from
the perspective of the surgeons, who did not want to apply the
international standards in that regard. Even though the interven-
tion was based on evidence-based international guidelines for
surgical prophylaxis 10, barriers to successful changes in prescribing
practices, particularly to shortening the duration of surgical pro-
phylaxis, have included poor awareness of antimicrobial resistance,
surgeons’ resistance to changing routine practices, and the strong
belief that hospitals in Egypt are different in terms of increased
contamination.
The beneﬁts of AMS for surgical prophylaxis have been
demonstrated in various studies. Van Kasteren et al14 reported that
the rate of appropriate prophylactic antibiotic administration rose
from 0.4% to 25% after education. In a study conducted by Prado
et al,15 the rate of appropriate surgical prophylaxis increased from
54% to 100% after an educational intervention. Nonetheless, other
international guidelines consider the effect of interventions that
depend on education as only marginally effective in changing
antimicrobial prescription practices.1
This pilot study proved effective in showing that an AMS (tar-
geting surgeons and anesthesiologists) that focused on education
and was supported by auditing and feedback of prescribed antibi-
otics had a signiﬁcant impact on improving surgical prophylaxis
practices, even though there remains considerable room for
improvement. Further studies to demonstrate the important eco-
nomic beneﬁts and long-term ﬁnancial impact of stewardship is
needed to make the AMS programs an integral part of all health
care facilities.Acknowledgments
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